OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Stock

Certificat

DE000GQ8FW64

Market Closed - BOERSE MUENCHEN 14:26:26 2024-06-28 EDT
0.232 EUR +6.91% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month-50.32%
1 month-42.72%
Date Price Change
24-06-28 0.232 +6.91%
24-06-27 0.217 -11.79%
24-06-26 0.246 -9.56%
24-06-25 0.272 -19.29%
24-06-24 0.337 -11.32%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 02:26 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GQ8FW6
ISINDE000GQ8FW64
Date issued 2023-11-02
Strike 82.38 $
Maturity Unlimited
Parity 25 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.957
Lowest since issue 0.169

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
87.3 USD
Average target price
109.7 USD
Spread / Average Target
+25.68%
Consensus